$63.07
1.94% today
Nasdaq, Jul 02, 09:54 pm CET
ISIN
US74276L1052
Symbol
PRCT
Sector

PROCEPT BioRobotics Target price 2024 - Analyst rating & recommendation

PROCEPT BioRobotics Classifications & Recommendation:

Buy
89%
Hold
11%

PROCEPT BioRobotics Target price

Target price $74.00
Course $61.87
Price potential
Number of estimates 7
7 Analysts have issued a price target PROCEPT BioRobotics 2025 . The average PROCEPT BioRobotics target price is $74.00. This is higher than the current share price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 8 Analysts recommend PROCEPT BioRobotics to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the PROCEPT BioRobotics share has an average upside potential 2025 of . Most analysts recommend the PROCEPT BioRobotics share at Purchase.

Sales and margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Turnover Million $ 136.19 213.73
81.56% 56.94%
EBITDA margin -77.36% -35.31%
24.05% 54.36%
Net margin -84.52% -46.71%
37.05% 44.74%

9 Analysts have issued a sales forecast PROCEPT BioRobotics 2024 . The average PROCEPT BioRobotics sales estimate is

$214m
Unlock
. This is
36.72% higher
Unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
$215m 37.34%
Unlock
, the lowest is
$213m 36.32%
Unlock
.

This results in the following potential growth figures:

Sales forecast

2023 $136m 81.56%
2024
$214m 56.94%
Unlock
2025
$300m 40.58%
Unlock
2026
$395m 31.54%
Unlock
2027
$501m 26.64%
Unlock
2028
$558m 11.49%
Unlock

6 Analysts have issued an PROCEPT BioRobotics EBITDA forecast 2024. The average PROCEPT BioRobotics EBITDA estimate is

$-75.5m
Unlock
. This is
27.73% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-69.6m 33.34%
Unlock
, the lowest is
$-101m 3.47%
Unlock
.

This results in the following potential growth figures and future EBITDA margins:

EBITDA forecast

2023 $-105m 37.89%
2024
$-75.5m 28.37%
Unlock
2025
$-48.0m 36.45%
Unlock
2026
$-31.9m 33.55%
Unlock

EBITDA margin

2023 -77.36% 24.05%
2024
-35.31% 54.36%
Unlock
2025
-15.96% 54.80%
Unlock
2026
-8.06% 49.50%
Unlock

4 PROCEPT BioRobotics Analysts have issued a net profit forecast 2024. The average PROCEPT BioRobotics net profit estimate is

$-99.8m
Unlock
. This is
8.37% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-99.2m 8.96%
Unlock
, the lowest is
$-101m 7.55%
Unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 $-115m 14.29%
2024
$-99.8m 13.28%
Unlock
2025
$-79.3m 20.60%
Unlock
2026
$-45.7m 42.30%
Unlock
2027
$-21.1m 53.94%
Unlock

Net margin

2023 -84.52% 37.05%
2024
-46.71% 44.74%
Unlock
2025
-26.38% 43.52%
Unlock
2026
-11.57% 56.14%
Unlock
2027
-4.21% 63.61%
Unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Earnings per share $ -2.24 -1.94
14.29% 13.39%
P/E ratio negative
EV/Sales 14.21

4 Analysts have issued a PROCEPT BioRobotics forecast for earnings per share. The average PROCEPT BioRobotics <a href=/blog/eps>EPS is

$-1.94
Unlock
. This is
8.49% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
$-1.93 8.96%
Unlock
, the lowest is
$-1.96 7.55%
Unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 $-2.24 14.29%
2024
$-1.94 13.39%
Unlock
2025
$-1.54 20.62%
Unlock
2026
$-0.89 42.21%
Unlock
2027
$-0.41 53.93%
Unlock

P/E ratio

Current -29.16 66.25%
2024
-31.85 9.22%
Unlock
2025
-40.11 25.93%
Unlock
2026
-69.52 73.32%
Unlock
2027
-150.90 117.06%
Unlock

Based on analysts' sales estimates for 2024, the PROCEPT BioRobotics share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

14.21
Unlock
and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of
14.89
Unlock
.

This results in the following potential growth figures and future valuations:

EV/Sales

Current 19.43 11.16%
2024
14.21 26.86%
Unlock
2025
10.11 28.87%
Unlock
2026
7.69 23.98%
Unlock
2027
6.07 21.04%
Unlock
2028
5.44 10.31%
Unlock

P/S ratio

Current 20.35 9.01%
2024
14.89 26.86%
Unlock
2025
10.59 28.87%
Unlock
2026
8.05 23.98%
Unlock
2027
6.36 21.04%
Unlock
2028
5.70 10.30%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today